Biological Injectables for OA; What, When and Why? Welcome

Description

The dialogue is from a discussion led by Mark Bowditch, a consultant orthopedic surgeon focused on innovations in joint regeneration therapies. He opens by highlighting the potential benefits of new injection techniques that could delay or prevent invasive surgeries, but emphasizes the importance of carefully evaluating these technologies before implementation. Mark invites a range of expert speakers to provide insights into the current landscape of joint therapies, discussing when and why certain methods may be appropriate. He mentions his own uncertainty in responding to patients' inquiries about these therapies, reflecting a common challenge in the medical field regarding emerging treatments. The session is co-chaired by him, Fares Haddad, a prominent orthopedic surgeon at UCL, and Caroline Hing, with Fares expected to set the stage for the discussion.

DOI: 10.1302/3114-221761

Specialties